Pictet Asset Management Holding SA Has $4.16 Million Stock Position in DaVita Inc. (NYSE:DVA)

Pictet Asset Management Holding SA cut its holdings in shares of DaVita Inc. (NYSE:DVA) by 3.6% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 27,838 shares of the company’s stock after selling 1,049 shares during the quarter. Pictet Asset Management Holding SA’s holdings in DaVita were worth $4,163,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Franklin Resources Inc. boosted its holdings in shares of DaVita by 134.6% during the third quarter. Franklin Resources Inc. now owns 54,901 shares of the company’s stock worth $8,885,000 after purchasing an additional 31,502 shares during the period. FMR LLC boosted its stake in shares of DaVita by 659.9% during the 3rd quarter. FMR LLC now owns 177,406 shares of the company’s stock valued at $29,082,000 after buying an additional 154,061 shares during the period. Assenagon Asset Management S.A. grew its holdings in shares of DaVita by 201.7% during the 4th quarter. Assenagon Asset Management S.A. now owns 74,617 shares of the company’s stock valued at $11,159,000 after acquiring an additional 49,885 shares in the last quarter. Neo Ivy Capital Management acquired a new position in shares of DaVita in the third quarter worth $726,000. Finally, Hussman Strategic Advisors Inc. raised its holdings in shares of DaVita by 200.0% during the fourth quarter. Hussman Strategic Advisors Inc. now owns 25,200 shares of the company’s stock worth $3,769,000 after acquiring an additional 16,800 shares in the last quarter. Hedge funds and other institutional investors own 90.12% of the company’s stock.

DaVita Trading Down 2.8 %

Shares of DVA stock opened at $149.37 on Friday. DaVita Inc. has a 12 month low of $125.64 and a 12 month high of $179.60. The company has a market cap of $11.95 billion, a PE ratio of 13.91, a price-to-earnings-growth ratio of 1.07 and a beta of 1.04. The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.18. The business’s 50 day moving average is $155.75 and its two-hundred day moving average is $157.28.

DaVita (NYSE:DVA) last posted its earnings results on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. Equities analysts predict that DaVita Inc. will post 10.76 EPS for the current year.

Analysts Set New Price Targets

Several research analysts have weighed in on DVA shares. StockNews.com lowered DaVita from a “buy” rating to a “hold” rating in a research report on Wednesday. Sanford C. Bernstein set a $184.00 price objective on DaVita in a report on Friday, February 21st. Barclays lifted their target price on shares of DaVita from $164.00 to $169.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 18th. Finally, Cowen restated a “hold” rating on shares of DaVita in a research note on Tuesday, February 18th. One analyst has rated the stock with a sell rating, five have issued a hold rating and one has given a buy rating to the stock. According to data from MarketBeat.com, DaVita presently has a consensus rating of “Hold” and an average target price of $166.33.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.